Acadian Asset Management’s Taysha Gene Therapies TSHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-26,477
| Closed | -$75K | – | 1908 |
|
|
2024
Q1 | $75K | Sell |
26,477
-433,589
| -94% | -$1.23M | ﹤0.01% | 1330 |
|
|
2023
Q4 | $813K | Buy |
+460,066
| New | +$813K | ﹤0.01% | 918 |
|
|
2023
Q3 | – | Sell |
-70,798
| Closed | -$46K | – | 1848 |
|
|
2023
Q2 | $46K | Sell |
70,798
-334,503
| -83% | -$217K | ﹤0.01% | 1544 |
|
|
2023
Q1 | $321K | Buy |
405,301
+143,450
| +55% | +$114K | ﹤0.01% | 1154 |
|
|
2022
Q4 | $590K | Buy |
261,851
+208,404
| +390% | +$470K | ﹤0.01% | 989 |
|
|
2022
Q3 | $102K | Hold |
53,447
| – | – | ﹤0.01% | 1360 |
|
|
2022
Q2 | $199K | Buy |
+53,447
| New | +$199K | ﹤0.01% | 1198 |
|